Medical technology and supplies company Semler Scientific (SMLR.US) revealed that has bought 581 BTC for about $40 million. Following this announcement, its shares rose by more than 31%. The company indicated that Bitcoin has been gaining tremendous popularity in recent months, after SEC greenlight January 11 and will prove to be a hedge against rising inflation or global instability in the future. Semler decided to invest its cash surpluses precisely in BTC, and the company's CEO Eric Semler stressed that the strategy of allocating capital surpluses in BTC will be maintained in the long term.
- At the same time, the company is focused on maintaining sales of QuantaFlo and is awaiting approval from the FDA for additional use of its proprietary technology, in cardiovascular diagnostics and treatment. Given the company's capitalization of $212 million, we can expect that its shares may prove sensitive to future price fluctuations and Bitcoin volatility. Microstrategy's CEO, Michael Saylor blissfully relayed the company's statement via the X platform.
- Semler Scientific has no debt and remains a profitable company, although the market's recent concern has been a problem with sustained revenue growth and slightly lower margins. Also, Bitcoin investment may be a signal that a company didn't recognize a more effective way of capital allocation and may have a problem with scaling its core business.
Semler Scientific (SMLR.US) shares, H1 interval
Source: xStation5
Start investing today or test a free demo
Open account Try demo Download mobile app Download mobile appThis content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
